ArticleHealth science reports2026
Prevalence, Clinical Profiles, Disease Severity, and Patient Outcomes of Alcoholic Liver Disease in a Tertiary Care Hospital of Nepal.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Alcoholic liver disease (ALD) is an increasingly prevalent, chronic lifestyle-related disease, which poses a significant global public health challenge. Timely detection and intervention are critical to reducing morbidity and mortality. This study aims to enhance understanding of ALD by identifying clinical profiles and factors influencing the patient's outcome in a tertiary care hospital in Nepal. Methodology: A descriptive cross-sectional study was conducted on 384 patients over 20 years old with chronic alcohol intake and signs of liver disease, admitted to the internal medicine ward at a tertiary care hospital in Nepal, from May 12, 2023, to November 20, 2023. Data were recorded after ethical approval using a convenience sampling method. A total of 384 samples were included as per the inclusion criteria, and data were recorded for symptomology for ALD, Model for End-Stage Liver Disease (MELD) score, and demographics. Result: The results showed that among 384 patients, 79.68% (306) were male and 20.32% (78) female, with a mean age of 46 ± 12.6 years. Common presentations included jaundice (77.34%), abdominal distention (76.56%), and melena (61%). MELD scores indicated advanced disease 12.50% scored 10-19, 33.03% scored 20-29, 39.06% scored 30-39, and 15.01% scored > 40. The overall mortality rate was 14.06%, which was higher in females 17.72% compared to males, 13.07%. Conclusion: This study found a higher prevalence of ALD than in similar studies, reinforcing the importance of early detection and comprehensive management strategies. The insights gained contribute to the objective of improving care for individuals with ALD, emphasizing the need for targeted interventions in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.